In a murine GBM model, ICOVIR17-mediated HA degradation also facilitates NF-κB activation in macrophages, reversing the immunosuppressive tumor microenvironment and promoting anti-tumor immune responses [91]. This evidence concerns the gene NFKB1 and glioblastoma.